Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jos Boesten"'
Publikováno v:
PLoS ONE, Vol 17, Iss 2, p e0264343 (2022)
ObjectiveAfter stratifying for age, sex and multimorbidity at baseline, our aim is to analyse time trends in incident multimorbidity and polypharmacy in the 15-year clinical trajectories of individual patients in a family medicine setting.MethodsThis
Externí odkaz:
https://doaj.org/article/ca84454dd0184e6598f02e3074840225
Autor:
EFSA Scientific Committee, Simon More, Vasileios Bampidis, Diane Benford, Jos Boesten, Claude Bragard, Thorhallur Halldorsson, Antonio Hernandez‐Jerez, Susanne Hougaard‐Bennekou, Kostas Koutsoumanis, Hanspeter Naegeli, Søren Saxmose Nielsen, Dieter Schrenk, Vittorio Silano, Dominique Turck, Maged Younes, Gabriele Aquilina, Riccardo Crebelli, Rainer Gürtler, Karen Ildico Hirsch‐Ernst, Pasquale Mosesso, Elsa Nielsen, Roland Solecki, Maria Carfì, Carla Martino, Daniela Maurici, Juan Parra Morte, Josef Schlatter
Publikováno v:
EFSA Journal, Vol 17, Iss 1, Pp n/a-n/a (2019)
Abstract The EFSA Scientific Committee addressed in this document the peculiarities related to the genotoxicity assessment of chemical mixtures. The EFSA Scientific Committee suggests that first a mixture should be chemically characterised as far as
Externí odkaz:
https://doaj.org/article/9fb20cf2ce074404896b499ed2599a71
Publikováno v:
PloS one. 17(2)
After stratifying for age, sex and multimorbidity at baseline, our aim is to analyse time trends in incident multimorbidity and polypharmacy in the 15-year clinical trajectories of individual patients in a family medicine setting.This study was carri
Publikováno v:
BMC Family Practice
BMC Family Practice, 16:2. BioMed Central Ltd
BMC Family Practice, 16:2. BioMed Central Ltd
BACKGROUND: Physicians are frequently confronted with complex health situations of patients, but knowledge of intensive forms of multimorbidity and their development during life is lacking. This study explores patterns and trajectories of chronic hea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::946f63fabcc217268ac3ee433552e117
https://lirias.kuleuven.be/handle/123456789/509321
https://lirias.kuleuven.be/handle/123456789/509321
Publikováno v:
European Journal of Clinical Pharmacology
European Journal of Clinical Pharmacology, 67, 91-6
European Journal of Clinical Pharmacology, 67(1), 91-96. Springer
European Journal of Clinical Pharmacology, 67, 1, pp. 91-6
European Journal of Clinical Pharmacology, 67, 91-6
European Journal of Clinical Pharmacology, 67(1), 91-96. Springer
European Journal of Clinical Pharmacology, 67, 1, pp. 91-6
Contains fulltext : 95791.pdf (Publisher’s version ) (Open Access) : Since guidelines on antibiotic drug treatment often focus on appropriate first choice drugs, assessment of guideline adherence should only concentrate on the first drug prescribed
Autor:
M.W.M. de Waal, N. Hoeymans, Jos Boesten, M. van den Akker, Henk J. Brouwer, Gijsen R, Gert P. Westert, C. van den Dungen, W.J. van der Veen, Robert A Verheij, Hugo M. Smeets, François G. Schellevis
Publikováno v:
van den Dungen, C, Hoeymans, N, Gijsen, R, van den Akker, M, Boesten, J, Brouwer, H, Smeets, H, van der Veen, W J, Verheij, R A, de Waal, M W M, Schellevis, F G & Westert, G P 2008, ' What factors explain the differences in morbidity estimations among general practice registration networks in the Netherlands? A first analysis ', European Journal of General Practice, vol. 14 Suppl 1, pp. 53-62 . https://doi.org/10.1080/13814780802436218
European Journal of General Practice, 14(1), 53-62. TAYLOR & FRANCIS LTD
European Journal of General Practice, 14 Suppl 1, 53-62
European Journal of General Practice, 14(1), 53-62. Informa Healthcare
European Journal of General Practice, 14(1), 53-62. TAYLOR & FRANCIS LTD
European Journal of General Practice, 14 Suppl 1, 53-62
European Journal of General Practice, 14(1), 53-62. Informa Healthcare
BACKGROUND: Information on the incidence and prevalence of diseases is a core indicator for public health. There are several ways to estimate morbidity in a population (e.g., surveys, healthcare registers). In this paper, we focus on one particular s
Autor:
Inez H.G.B. Ramakers, Jos Boesten, Jelle Jolles, Frans R.J. Verhey, Pieter Jelle Visser, Pauline Aalten, Job F. M. Metsemakers
Publikováno v:
Dementia and Geriatric Cognitive Disorders, 24(4), 300-306. Karger
Ramakers, I H G B, Visser, P J, Aalten, P, Boesten, J H M, Metsemakers, J F M, Jolles, J & Verhey, F R J 2007, ' Symptoms of preclinical dementia in general practice up to five years before dementia diagnosis ', Dementia and Geriatric Cognitive Disorders, vol. 24, no. 4, pp. 300-306 . https://doi.org/10.1159/000107594
Dementia and Geriatric Cognitive Disorders, 24(4), 300-306. S. Karger AG
Ramakers, I H G B, Visser, P J, Aalten, P, Boesten, J H M, Metsemakers, J F M, Jolles, J & Verhey, F R J 2007, ' Symptoms of preclinical dementia in general practice up to five years before dementia diagnosis ', Dementia and Geriatric Cognitive Disorders, vol. 24, no. 4, pp. 300-306 . https://doi.org/10.1159/000107594
Dementia and Geriatric Cognitive Disorders, 24(4), 300-306. S. Karger AG
Objectives:To investigate which symptoms are indicative of preclinical dementia in general practice and whether subjects with preclinical dementia have an increased contact frequency with their general practitioner (GP). Methods: Individuals with pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72e7f9a5ed5f0c3eba985dab1f28885d
https://cris.maastrichtuniversity.nl/en/publications/6f291323-9486-427e-8624-c7afb05bac0f
https://cris.maastrichtuniversity.nl/en/publications/6f291323-9486-427e-8624-c7afb05bac0f